- Home
- CTOR vs MKTW Comparison
CTOR vs MKTW Comparison
Compare CTOR & MKTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTOR
- MKTW
- Stock Information
- Founded
- CTOR 2021
- MKTW 1999
- Country
- CTOR United States
- MKTW United States
- Employees
- CTOR N/A
- MKTW N/A
- Industry
- CTOR
- MKTW Computer Software: Prepackaged Software
- Sector
- CTOR
- MKTW Technology
- Exchange
- CTOR NYSE
- MKTW Nasdaq
- Market Cap
- CTOR 52.2M
- MKTW 45.4M
- IPO Year
- CTOR N/A
- MKTW N/A
- Fundamental
- Price
- CTOR $0.95
- MKTW $16.32
- Analyst Decision
- CTOR Buy
- MKTW
- Analyst Count
- CTOR 2
- MKTW 0
- Target Price
- CTOR $6.00
- MKTW N/A
- AVG Volume (30 Days)
- CTOR 42.7K
- MKTW 27.0K
- Earning Date
- CTOR 05-14-2025
- MKTW 05-08-2025
- Dividend Yield
- CTOR N/A
- MKTW 4.52%
- EPS Growth
- CTOR N/A
- MKTW 207.28
- EPS
- CTOR N/A
- MKTW 3.12
- Revenue
- CTOR N/A
- MKTW $383,217,000.00
- Revenue This Year
- CTOR N/A
- MKTW N/A
- Revenue Next Year
- CTOR N/A
- MKTW $0.42
- P/E Ratio
- CTOR N/A
- MKTW $5.24
- Revenue Growth
- CTOR N/A
- MKTW N/A
- 52 Week Low
- CTOR $0.55
- MKTW $9.08
- 52 Week High
- CTOR $49.00
- MKTW $29.00
- Technical
- Relative Strength Index (RSI)
- CTOR N/A
- MKTW 55.47
- Support Level
- CTOR N/A
- MKTW $15.42
- Resistance Level
- CTOR N/A
- MKTW $18.78
- Average True Range (ATR)
- CTOR 0.00
- MKTW 0.89
- MACD
- CTOR 0.00
- MKTW -0.12
- Stochastic Oscillator
- CTOR 0.00
- MKTW 30.90
About CTOR CITIUS ONCOLOGY INC
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.
About MKTW MarketWise Inc.
Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.